NCT07477327

Brief Summary

Treatment Arms for Randomization

  • Advantage: Provides stable conditions for fracture healing.
  • Disadvantage: Risk of muscle atrophy and ankle joint stiffness due to prolonged immobilization.
  • Functional treatment: Weightbearing as tolerated using a rigid-sole shoe.
  • Advantage: Allows early mobilization, reduces muscle atrophy, and helps maintain ankle mobility.
  • Disadvantage: Potential concern regarding pain, insufficient fracture stabilization, or pseudarthrosis Study Objectives This research project focuses on the treatment of Chopart fractures. In recent years, the number of diagnosed fractures following ankle sprains has increased. This rise is likely due to improved awareness of these injuries and the more frequent use of advanced imaging techniques such as CT scans (Computed Tomography). However, the optimal treatment strategy for these fractures remains unclear. Current treatment approaches range from operative management to conservative treatment with 6-8 weeks of immobilization, and more recently to functional treatment protocols. Most of the available evidence consists of case series, representing a low level of evidence. High-quality comparative studies are currently lacking. As a public hospital, Hospital Cantonal Fribourg (HFR) manages a large number of regional trauma cases, including Chopart injuries, with an incidence of approximately 50 cases per year. At present, treatment at HFR is predominantly conservative, involving 8 weeks of immobilization in a cast or a VACOped boot. While immobilization allows sufficient time for fracture healing, it may result in muscle atrophy and ankle joint stiffness. Recent literature suggests that a more functional treatment approach may lead to promising results. However, it remains unclear whether earlier weightbearing and functional rehabilitation improve overall outcomes or result in prolonged pain and increases the risk of complications. Therefore, the aim of this study is to compare different non-operative treatment strategies using both patient-reported outcome measures and objective gait analysis. The primary objective of this study is to evaluate patient-reported outcomes following different non-operative treatment strategies for Chopart fractures. In addition, the study will assess differences in gait patterns between the two study arms and correlate these findings with patient-reported outcomes and quality of life. The study also aims to determine the timeline required to regain a normal gait pattern after injury. Outcome Measures The primary outcome will be patient-reported functional outcome and quality of life, assessed using a 22-item questionnaire combining the EFAS Score (European Foot and Ankle Society) and the Short Form-12 health survey. The secondary outcome will be objective gait analysis parameters.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
49mo left

Started Oct 2026

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 17, 2026

Completed
7 months until next milestone

Study Start

First participant enrolled

October 1, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2030

Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

March 2, 2026

Last Update Submit

March 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient reported outcome

    European foot and ankle society score; minimum score of 0 points (worst possible) and a maximum score of 24 points (best possible).

    6 weeks, 3 months, 6 months, 1 year

Secondary Outcomes (1)

  • Quality of life

    6 weeks, 3 months, 6 months, 1 year

Other Outcomes (1)

  • Gait analysis

    6 weeks, 3 months, 6 months, 1 year

Study Arms (2)

Restrictive treatment:

ACTIVE COMPARATOR

Immobilization in a cast or VACOped boot for 6 weeks

Other: 6 weeks cast immobilization

Functional treatment

OTHER

Weightbearing as tolerated using a rigid-sole shoe.

Other: Rigide sole

Interventions

6 weeks cast immobilization

Restrictive treatment:

6 weeks of weight bearing as tolerated

Functional treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged above 18 years
  • Patient with a pure ligament Chopart injury or bony avulsion of the ligaments of the Chopart joint line
  • Patient expected to complete length of study

You may not qualify if:

  • Patient which does not understand the informed consent (due to language capacity or mental capacity)
  • Patient non ambulating before time of injury
  • Patient treated for the fracture outside of Hopital Cantonal Fribourg (the study side)
  • Patient treated for a fracture at the same foot/ ankle before

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2026

First Posted

March 17, 2026

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

October 1, 2030

Last Updated

March 17, 2026

Record last verified: 2026-03